Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-27T21:48:16.709Z Has data issue: false hasContentIssue false
  • English
  • Français

Mechanisms and Presentations of Catatonia

Published online by Cambridge University Press:  07 November 2014

Brendan T. Carroll
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
CNS Spectrums , Volume 5 , Issue 7: Mechanisms and Presentations of Catatonia , July 2000 , pp. 25
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.KL, Kahlbaum, Y, Levij, T, Pridon, trans. Catatonia. Baltimore, MD: Johns Hopkins University Press; 1973.Google Scholar
2.Delay, J, Pichot, P, Lemperiere, T, et al.Un neuroleptique majeur non-phenothiazine et non reserpinique, I'haloperidol, dans le traitement des psychoses. Ann Med Psychol (Paris). 1960;118:145–152.Google Scholar
3.Fricchione, G, Mann, SC, Caroff, S. Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatric Annals. 2000;30:347–355.CrossRefGoogle Scholar
4.Mann, SC, Caroff, SN, Fricchione, G, et al.Central dopamine hypoactivity and the pathogenesis of neuroleptic malignant syndrome. Psychiatric Annals. 2000;30:363–374.CrossRefGoogle Scholar
5.Lauterbach, EC. Catatonia-like events after valproic acid with risperidone and sertraline. Neuropsychiatry, Neurovpsychol Behav Neurol. 1998;11:157–163.Google ScholarPubMed